UP!

IMMU $87.86

IMMU target price
87.86
0
0

Immunomedics is a pharmaceutical company focusing on the development of monoclonal antibodies for the treatment of disease.

Immunomedics was founded in July 1982 by David M. Goldenberg, who has served on the board of directors since then. Cynthia Sullivan is the current CEO. In 2016, they had 131 employees.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2020 2020-08-05 -0.30 -0.30
Q1 2020 2020-05-06 -0.44 -0.44
Q4 2019 2020-02-27 -0.50 -0.50
Q3 2019 2019-10-30 -0.49 -0.49
Q2 2019 2019-08-07 -0.40 -0.40
Q1 2019 2019-05-09 -0.46 -0.46

Ratings

2016-06-21 Downgrade Wells Fargo Outperform to Market Perform
2016-06-21 Downgrade Wells Fargo & Co. Outperform to Market Perform
2016-06-06 Reiterated Rating Jefferies Group Buy $5.00
2016-05-24 Reiterated Rating Wells Fargo Buy
2016-05-06 Upgrade Jefferies Group Hold to Buy $1.50 to $5.00
2016-03-15 Lower Price Target Jefferies Group Hold $2.00 to $1.50
2016-02-05 Upgrade Wells Fargo Market Perform to Buy
2015-12-04 Downgrade Wells Fargo Outperform to Market Perform
2015-07-29 Reiterated Rating Oppenheimer Outperform
2015-07-29 Downgrade Jefferies Group Buy to Hold $6.00 to $2.00
2015-07-29 Reiterated Rating Oppenheimer Holdings Inc. Outperform
2015-01-16 Initiated Coverage Wells Fargo & Co. Outperform to Fair Value
2015-01-16 Initiated Coverage Wells Fargo Outperform to Fair Value
2015-01-07 Initiated Coverage Wells Fargo & Co. Outperform to Outperform $7.00 to $7.25
2015-01-07 Initiated Coverage Wells Fargo Outperform to Outperform $7.00 to $7.25
2014-09-30 Reiterated Rating Panmure Gordon Buy
2014-09-23 Initiated Coverage Jefferies Group Buy $6.00
2014-08-27 Downgrade R. F. Lafferty Buy to Neutral $4.00
2014-01-08 Initiated Chardan Capital Markets Buy $9
2014-01-08 Initiated Coverage Chardan Capital Buy $9.00
2013-10-02 Boost Price Target Oppenheimer Outperform $6.00 to $8.00
2013-09-10 Initiated R. F. Lafferty Buy $8
2013-06-03 Initiated WallachBeth Buy $6
2011-08-31 Initiated Summer Street Research Buy $8
2011-07-28 Initiated Summer Street Research Buy $8
2011-02-23 Initiated Wedbush Outperform $6
2007-07-03 Initiated Brean Murray Buy $8
2007-02-20 Initiated Lazard Capital Buy $6
2016-06-21 Downgrade Wells Fargo Outperform to Market Perform
2016-06-21 Downgrade Wells Fargo & Co. Outperform to Market Perform
2016-06-06 Reiterated Rating Jefferies Group Buy $5.00
2016-05-24 Reiterated Rating Wells Fargo Buy
2016-05-06 Upgrade Jefferies Group Hold to Buy $1.50 to $5.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
venBio Select Advisor LLC See Remarks 20.29%  (16939461) IMMU / MRTX /
Aghazadeh Behzad See Remarrks 19.24%  (16064461) IMMU /
GOLDENBERG DAVID M CSO, CMO and Chairman 6.72%  (5613252) IMMU /
GOLDENBERG CYNTHIA L President and CEO 0.93%  (778219) IMMU /
GORMAN GERARD G SVP, Fin. & Bus. Dev. & CFO 0.14%  (115671) IMMU /
MARKISON BRIAN A 0.11%  (90788) ALR / IMMU / LNTH / PIP /
PAETZOLD MARY E 0.08%  (67474) IMMU /
Stark Don C 0.06%  (51748) IMMU /
COLEMAN MORTON 0.05%  (39950) IMMU /
PFREUNDSCHUH PETER P. Chief Financial Officer 0.04%  (29706) IMMU / SCMP /
LoCastro Marcella 0.02%  (14950) BIOC / IMMU /
Sherman Richard L. 0.01%  (12130) IMMU / TLOG /
ZUERBLIS KENNETH J 0.01%  (9167) IMMU / STML /
Wolynic Edward T 0.01%  (6667) IMMU /